These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37541723)

  • 1. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.
    Hervás-Corpión I; Alonso MM
    Int Rev Cell Mol Biol; 2023; 379():169-188. PubMed ID: 37541723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas.
    Stergiopoulos GM; Concilio SC; Galanis E
    Curr Treat Options Oncol; 2024 Jul; 25(7):952-991. PubMed ID: 38896326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review.
    Wang JL; Scheitler KM; Wenger NM; Elder JB
    Neurosurg Focus; 2021 Feb; 50(2):E2. PubMed ID: 33524943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Virotherapy for the Treatment of Malignant Glioma.
    Foreman PM; Friedman GK; Cassady KA; Markert JM
    Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promises of oncolytic viral therapy for adult and children with brain glioma.
    Patiño-García A; Alonso MM; Gállego Pérez-Larraya J
    Curr Opin Oncol; 2023 Nov; 35(6):529-535. PubMed ID: 37820087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical advances in oncolytic virotherapy for pediatric brain tumors.
    Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK
    Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncolytic viruses in the therapy of gliomas].
    Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.
    Omar NB; Bentley RT; Crossman DK; Foote JB; Koehler JW; Markert JM; Platt SR; Rissi DR; Shores A; Sorjonen D; Yanke AB; Gillespie GY; Chambers MR
    Neurosurg Focus; 2021 Feb; 50(2):E5. PubMed ID: 33524948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic virus therapy for malignant gliomas: entering the new era.
    Fudaba H; Wakimoto H
    Expert Opin Biol Ther; 2023 Mar; 23(3):269-282. PubMed ID: 36809883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.
    Zhang Q; Liu F
    Cell Death Dis; 2020 Jun; 11(6):485. PubMed ID: 32587256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic cellular viroimmunotherapy for canine high-grade gliomas.
    Cloquell A; Mateo I; Gambera S; Pumarola M; Alemany R; García-Castro J; Perisé-Barrios AJ
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
    Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM
    Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice.
    Shoaf ML; Desjardins A
    Neurotherapeutics; 2022 Oct; 19(6):1818-1831. PubMed ID: 35674873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.
    Zemp FJ; Corredor JC; Lun X; Muruve DA; Forsyth PA
    Cytokine Growth Factor Rev; 2010; 21(2-3):103-17. PubMed ID: 20483653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
    Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic virus in gliomas: a review of human clinical investigations.
    Carpenter AB; Carpenter AM; Aiken R; Hanft S
    Ann Oncol; 2021 Aug; 32(8):968-982. PubMed ID: 33771666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Bench to Bedside, the Current State of Oncolytic Virotherapy in Pediatric Glioma.
    Soldozy S; Skaff A; Soldozy K; Sokolowski JD; Norat P; Yagmurlu K; Sharifi KA; Tvrdik P; Park MS; Kalani MYS; Jane JA; Syed HR
    Neurosurgery; 2020 Nov; 87(6):1091-1097. PubMed ID: 32542365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.
    Zeng J; Li X; Sander M; Zhang H; Yan G; Lin Y
    Front Immunol; 2021; 12():721830. PubMed ID: 34675919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma.
    Bernstock JD; Blitz SE; Hoffman SE; Gerstl JVE; Chiocca EA; Friedman GK
    Neurooncol Adv; 2023; 5(1):vdad081. PubMed ID: 37497017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.